Early treatment with erythromycin of Campylobacter jejuni-associated dysentery in children.

PubWeight™: 1.36‹?› | Rank: Top 10%

🔗 View Article (PMID 3488385)

Published in J Pediatr on August 01, 1986

Authors

E Salazar-Lindo, R B Sack, E Chea-Woo, B A Kay, Z A Piscoya, R Leon-Barua, A Yi

Articles by these authors

Test for enterotoxigenic Escherichia coli using Y-1 adrenal cells in miniculture. Infect Immun (1975) 13.58

Human diarrheal disease caused by enterotoxigenic Escherichia coli. Annu Rev Microbiol (1975) 9.01

Enterotoxigenic Escherichia coli isolated from patients with severe cholera-like disease. J Infect Dis (1971) 7.10

Travelers' diarrhea in Mexico. A prospective study of physicians and family members attending a congress. N Engl J Med (1976) 6.52

Acute undifferentiated human diarrhea in the tropics. I. Alterations in intestinal micrflora. J Clin Invest (1971) 6.23

Large outbreak of clinical cholera due to Vibrio cholerae non-O1 in Bangladesh. Lancet (1993) 5.48

Immunologic cross-reactions of enterotoxins from Escherichia coli and Vibrio cholerae. J Infect Dis (1973) 5.46

Enzyme-linked immunosorbent assay for detection of Escherichia coli heat-labile enterotoxin. J Clin Microbiol (1977) 5.17

Special Escherichia coli serotypes among enterotoxigenic strains from diarrhoea in adults and children. Med Microbiol Immunol (1976) 4.95

Practice guidelines for the management of infectious diarrhea. Clin Infect Dis (2001) 4.49

Experimental canine cholera. I. Development of the model. J Infect Dis (1969) 4.02

Site and characteristics of electrolyte loss and effect of intraluminal glucose in experimental canine cholera. J Clin Invest (1968) 3.72

Simple adult rabbit model for Vibrio cholerae and enterotoxigenic Escherichia coli diarrhea. Infect Immun (1981) 3.69

Cytotoxic enterotoxin produced by Aeromonas hydrophila: relationship of toxigenic isolates to diarrheal disease. Infect Immun (1979) 3.65

Enterotoxigenic Escherichia coli isolated from food. J Infect Dis (1977) 3.52

Laboratory investigation of diarrhea in travelers to Mexico: evaluation of methods for detecting enterotoxigenic Echerichia coli. J Clin Microbiol (1976) 3.34

Diarrhoea associated with heat-stable enterotoxin-producing strains of Escherichia coli. Lancet (1975) 3.27

Oral rehydration therapy of infantile diarrhea: a controlled study of well-nourished children hospitalized in the United States and Panama. N Engl J Med (1982) 3.24

Optic flow is used to control human walking. Nat Neurosci (2001) 3.12

Case-control study of enteropathogens associated with childhood diarrhea in Dhaka, Bangladesh. J Clin Microbiol (1999) 3.11

Intestinal fluid and electrolyte transport in human cholera. J Clin Invest (1970) 3.09

A controlled trial of bismuth subsalicylate in infants with acute watery diarrheal disease. N Engl J Med (1993) 3.07

Progressive changes of Vibrio serotypes in germ-free mice infected with Vibrio cholerae. J Bacteriol (1969) 3.01

Antitoxin responses to infections with enterotoxigenic Escherichia coli. J Infect Dis (1974) 2.88

Prophylactic doxycycline for travelers' diarrhea. Results of a prospective double-blind study of Peace Corps volunteers in Kenya. N Engl J Med (1978) 2.86

Field trial of oral cholera vaccines in Bangladesh. Lancet (1986) 2.85

Enterotoxigenic Escherichia-coli-associated diarrheal disease in Apache children. N Engl J Med (1975) 2.74

Microtiter solid-phase radioimmunoassay for detection of Escherichia coli heat-labile enterotoxin. Infect Immun (1977) 2.72

Prevalence of toxin types and colonization factors in enterotoxigenic Escherichia coli isolated during a 2-year period from diarrheal patients in Bangladesh. J Clin Microbiol (2000) 2.69

Vibriocidal and agglutinating antibody patterns in cholera patients. J Infect Dis (1966) 2.67

El Tor cholera with severe disease: a new threat to Asia and beyond. Epidemiol Infect (2009) 2.60

Isolation of enterotoxigenic Bacteroides fragilis from humans with diarrhea. J Clin Microbiol (1987) 2.58

Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial. J Infect Dis (1988) 2.57

Methodological issues in diarrhoeal diseases epidemiology: definition of diarrhoeal episodes. Int J Epidemiol (1991) 2.56

Human colonic epithelial cells, HT29/C1, treated with crude Bacteroides fragilis enterotoxin dramatically alter their morphology. Infect Immun (1992) 2.41

Genotypes associated with virulence in environmental isolates of Vibrio cholerae. Appl Environ Microbiol (2001) 2.41

Functional recovery in parkinsonian monkeys treated with GDNF. Nature (1996) 2.35

Experimental non-O group 1 Vibrio cholerae gastroenteritis in humans. J Clin Invest (1990) 2.33

Virulence and phenotypic characterization of Yersinia enterocolitica isolated from humans in the United States. J Clin Microbiol (1983) 2.32

Replacement of water and electrolyte losses in cholera by an oral glucose-electrolyte solution. Ann Intern Med (1969) 2.28

Tissue-culture assay of antibodies to heat-liable Escherichia coli enterotoxins. N Engl J Med (1974) 2.20

Amebiasis and mucosal IgA antibody against the Entamoeba histolytica adherence lectin in Bangladeshi children. J Infect Dis (2001) 2.20

Enterotoxigenic Escherichia coli: identification and characterization. J Infect Dis (1980) 2.16

Immunity to experimental cholera. III. Enhanced duration of protection after sequential parenteral-oral administration of toxoid to dogs. J Infect Dis (1977) 2.13

Small bowel morphology in experimental canine cholera. A light and electron microscopic study. Lab Invest (1970) 2.12

Production, characterization, and application of monoclonal antibodies to Vibrio cholerae O139 synonym Bengal. Clin Diagn Lab Immunol (1994) 2.07

The aquatic flora and fauna as reservoirs of Vibrio cholerae: a review. J Diarrhoeal Dis Res (1994) 2.04

Enterotoxigenic Escherichia coli isolated from patients at a hospital in Dacca. J Infect Dis (1977) 2.03

New virulence-associated plasmid in Yersinia enterocolitica. J Clin Microbiol (1982) 2.03

Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1. Infect Immun (1997) 2.01

Relationship between enterotoxin production and serotype in enterotoxigenic Escherichia coli. Infect Immun (1979) 2.01

Cholera epidemics in Bangladesh: 1985-1991. J Diarrhoeal Dis Res (1992) 1.92

Enteropathogens associated with acute and persistent diarrhea in Bangladeshi children less than 5 years of age. J Infect Dis (1992) 1.91

Comparison of the vibriocidal antibody response in cholera due to Vibrio cholerae O139 Bengal with the response in cholera due to Vibrio cholerae O1. Clin Diagn Lab Immunol (1995) 1.89

Use of colony pools for diagnosis of enterotoxigenic Escherichia coli diarrhea. J Clin Microbiol (1979) 1.88

Enterotoxigenic Escherichia coli diarrhea of travelers: a prospective study of American Peace Corps volunteers. Johns Hopkins Med J (1977) 1.88

Experimental cholera. A canine model. Lancet (1966) 1.88

Acute toxicity of vitamin A given with vaccines in infancy. Lancet (1993) 1.87

Immunization with Escherichia coli enterotoxin protects against homologous enterotoxin challenge. Infect Immun (1973) 1.86

Prevalence of enterotoxin genes in Aeromonas spp. isolated from children with diarrhea, healthy controls, and the environment. J Clin Microbiol (2000) 1.85

Prophylactic doxycycline for travelers' diarrhea: results of a prospective double-blind study of Peace Corps volunteers in Morocco. Gastroenterology (1979) 1.84

Helicobacter pylori in developing countries. World Gastroenterology Organisation Global Guideline. J Gastrointestin Liver Dis (2011) 1.80

Molecular analysis of rRNA and cholera toxin genes carried by the new epidemic strain of toxigenic Vibrio cholerae O139 synonym Bengal. J Clin Microbiol (1994) 1.79

The O139 serogroup of Vibrio cholerae comprises diverse clones of epidemic and nonepidemic strains derived from multiple V. cholerae O1 or non-O1 progenitors. J Infect Dis (2000) 1.76

Field trial of oral cholera vaccines in Bangladesh: results of one year of follow-up. J Infect Dis (1988) 1.76

Antibodies to heat-labile Escherichia coli enterotoxin in Apaches in Whiteriver, Arizona. Infect Immun (1975) 1.75

Experimental canine cholera. II. Production by cell-free culture filtrates of Vibrio cholerae. J Infect Dis (1969) 1.69

New insights on the emergence of cholera in Latin America during 1991: the Peruvian experience. Am J Trop Med Hyg (2000) 1.66

The spatial epidemiology of cholera in an endemic area of Bangladesh. Soc Sci Med (2002) 1.65

Acute respiratory infections in children: a community-based longitudinal study in rural Bangladesh. J Trop Pediatr (1997) 1.64

The epidemiology of Helicobacter pylori in Peruvian children between 6 and 30 months of age. Am J Gastroenterol (1994) 1.62

Helicobacter pylori populations in Peruvian patients. Clin Infect Dis (1997) 1.57

Antigenic similarity of heat-labile enterotoxins from diverse strains of Escherichia coli. J Clin Microbiol (1977) 1.55

Identifying environmental risk factors for endemic cholera: a raster GIS approach. Health Place (2002) 1.49

Prospective study of systemic and mucosal immune responses in dysenteric patients to specific Shigella invasion plasmid antigens and lipopolysaccharides. Infect Immun (1991) 1.47

Development and evaluation of rapid monoclonal antibody-based coagglutination test for direct detection of Vibrio cholerae O139 synonym Bengal in stool samples. J Clin Microbiol (1994) 1.47

The efficacy of bismuth subsalicylate in the treatment of acute diarrhoea and the prevention of persistent diarrhoea. Acta Paediatr (2001) 1.47

Toxin production by Vibrio mimicus strains isolated from human and environmental sources in Bangladesh. J Clin Microbiol (1987) 1.46

Rotavirus diarrhea in Bangladeshi children: correlation of disease severity with serotypes. J Clin Microbiol (1992) 1.44

The current status of oral therapy in the treatment of acute diarrheal illness. Am J Clin Nutr (1978) 1.43

Diagnostic limitations to accurate diagnosis of cholera. J Clin Microbiol (2010) 1.43

Comparison of three methods to obtain upper small bowel contents for culture. Am J Gastroenterol (1993) 1.41

Colonization factor antigens I and II and type 1 somatic pili in enterotoxigenic Escherichia coli: relation to enterotoxin type. Infect Immun (1983) 1.41

Field trial of inactivated oral cholera vaccines in Bangladesh: results from 5 years of follow-up. Vaccine (1996) 1.39

Racecadotril in the treatment of acute watery diarrhea in children. N Engl J Med (2000) 1.38

Molecular subtyping of toxigenic Vibrio cholerae O139 causing epidemic cholera in India and Bangladesh, 1992-1993. J Infect Dis (1995) 1.37

Clonal relationships among classical Vibrio cholerae O1 strains isolated between 1961 and 1992 in Bangladesh. J Clin Microbiol (1993) 1.36

Differentiation of Shigella flexneri strains by rRNA gene restriction patterns. J Clin Microbiol (1992) 1.35

Comparison of sucrose and glucose in the oral electrolyte therapy of cholera and other severe diarrheas. N Engl J Med (1977) 1.35

Lack of cross-protection against diarrhea due to Vibrio cholerae O139 (Bengal strain) after oral immunization of rabbits with V. cholerae O1 vaccine strain CVD103-HgR. J Infect Dis (1994) 1.35

Phenotypic diversity of enterotoxigenic Escherichia coli strains from a community-based study of pediatric diarrhea in periurban Egypt. J Clin Microbiol (1999) 1.35

Yersinia enterocolitica isolated from two cohorts of young children in Santiago, Chile: incidence of and lack of correlation between illness and proposed virulence factors. J Clin Microbiol (1991) 1.34

Role of soy-based, lactose-free formula during treatment of acute diarrhea. Pediatrics (1985) 1.34

Space-time behavior of single and bimanual rhythmical movements: data and limit cycle model. J Exp Psychol Hum Percept Perform (1987) 1.32

Biotype as determinant of natural immunising effect of cholera. Lancet (1991) 1.32

DNA probe analysis of diarrhoeagenic Escherichia coli: detection of EAF-positive isolates of traditional enteropathogenic E. coli serotypes among Bangladeshi paediatric diarrhoea patients. Mol Cell Probes (1992) 1.32